Stein-Gold, L., Elewski, B., Draelos, Z. and Lin, T. (2020) “Safety and Efficacy of a Fixed Combination Halobetasol Propionate 0.01%/Tazarotene 0.045% (HP/TAZ) Lotion in the Treatment of Females With Moderate-to-Severe Plaque Psoriasis”, SKIN The Journal of Cutaneous Medicine, 4(1), p. S9. Available at: https://jofskin.org/33014/index.php/skin/article/view/822 (Accessed: 3 July 2024).